Ichiro Mori

Title: Ichiro Mori: Innovator in Topical Patch Preparations

Introduction

Ichiro Mori is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of medical technology, particularly in the development of topical patch preparations. His innovative work focuses on enhancing the administration of delayed-type hypersensitivity inducers for therapeutic applications.

Latest Patents

Ichiro Mori holds a patent for a topical patch preparation that contains a delayed-type hypersensitivity inducer. The patent, titled "Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same," describes a formulation that includes 1-dichloro-2,4-dinitrobenzene (DNCB) as the active component. The adhesive gel composition is designed to be applied to the skin surface, allowing for effective delivery of the hypersensitivity inducer within a maintenance period that typically does not exceed 60 minutes. This invention is particularly beneficial for treating HIV-associated disease conditions, such as AIDS.

Career Highlights

Ichiro Mori is associated with Teikoku Pharma USA, Inc., where he continues to advance his research and development efforts. His work has led to innovative solutions that address critical health challenges, showcasing his commitment to improving patient care through technology.

Collaborations

Ichiro collaborates with Jutaro Shudo, contributing to the advancement of their shared goals in medical innovation.

Conclusion

Ichiro Mori's contributions to the field of topical patch preparations highlight his role as a key innovator in medical technology. His patent reflects a significant advancement in the administration of therapeutic agents, particularly for HIV-related conditions.